CDC7 and cancer: Drug targets (such as CDC7 and its inhibitor XL413), drug combination therapies, the phenomenon of resistance in cancer treatment, and ways to mitigate this phenomenon through various pathways are some of the important aspects of drug resistance that are covered in this review, which offers a more thorough investigation of the complex mechanisms of resistance.